[Targets of antileukemia agents: molecular mechanisms of mercaptopurine action].
Krynetskaia
N F
NF
natalia.krynetskaia@stjude.org
Krynetskiĭ
E Iu
EIu
D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology* / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000378:metabolism; D006151:Guanosine / Q000378:metabolism; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D015122:Mercaptopurine / Q000494:pharmacology* / Q000627:therapeutic use; D008780:Methyltransferases / Q000235:genetics / Q000378:metabolism; D009692:Nucleic Acid Heteroduplexes; D010802:Phylogeny; D011110:Polymorphism, Genetic
D018906:Antineoplastic Agents, Alkylating; D004273:DNA, Neoplasm; D009692:Nucleic Acid Heteroduplexes; D006151:Guanosine; D015122:Mercaptopurine; D008780:Methyltransferases; C022745:thiopurine methyltransferase